Messaging Framework
Ovvio Health — Fertility Tracking App, D2C-to-Enterprise Benefits Channel Pivot
Date: 2026-05-30 · Prepared by: Resolvix · Status: Sample Deliverable
Deliverable type: Go-to-Market — Messaging Framework (~$650)
Industry: Women's Health / Femtech (Fertility Tracking, Employer Benefits Channel)
About this sample. This is one example of what a successful Resolvix deliverable looks like at this scope and type — not a template that every engagement follows. Your expert brings their own expertise and judgment to the work: the structure, the emphasis, which angles they dig into, and how they organize their findings will all vary based on your industry, your specific question, and where the research leads. What stays consistent across every engagement is the standard: analysis grounded in evidence, prioritized recommendations, concrete action steps, and a phased implementation plan. All company names, figures, and scenarios in this sample are illustrative.
Executive Summary
Ovvio Health has spent three years building a direct-to-consumer fertility tracking app with 280,000 active users, strong retention metrics, and genuine clinical credibility (98.2% cycle prediction accuracy, peer-reviewed validation study published in 2024). The pivot to an employer benefits channel is strategically sound — the fertility benefits market grew from $400M to $1.4B in employer spend between 2021 and 2025, and CFOs are increasingly willing to fund fertility support as a retention and recruiting tool.
The messaging problem, however, is substantial. The D2C voice Ovvio has built — warm, personal, focused on individual empowerment and emotional journeys — does not translate to enterprise HR buyers evaluating benefits platforms against a spreadsheet. The HR buyer needs population-level ROI, liability risk reduction, benefits administration simplicity, and employee utilization data. She does not need to feel what it's like to get a period prediction right.
This framework defines Ovvio's enterprise positioning, the message hierarchy for each buyer persona, specific taglines and positioning statements tested against the competitive landscape, and the full message architecture for sales decks, website, and outbound sequences. The D2C voice is preserved as a proof point — it becomes evidence of user trust and clinical credibility — but it is repositioned inside an enterprise frame.
1. Competitive Landscape and Positioning Context
1.1 The Enterprise Fertility Benefits Market
Ovvio competes in the employer-sponsored fertility benefits category alongside:
- Progyny ($PGNY): The market leader for IVF and advanced reproductive technology benefits. Covered by ~460 self-insured employers. Focused exclusively on fertility treatment financing, not cycle tracking or holistic fertility health. Average employer contract: $800K–$3M annually. Targets Fortune 500 HR.
- Carrot Fertility: Global fertility benefits platform covering IVF, egg freezing, surrogacy, and adoption. $400–$600 PEPM for comprehensive coverage. Positioning: "equity-first fertility benefits." Strong on the DEI angle.
- Maven Clinic: Women's and family health virtual clinic. Includes fertility, OB/GYN, mental health, pediatrics. $18–$35 PEPM. Broader scope than pure fertility; weaker on cycle tracking and clinical specificity.
- Ovia Health (part of Labcorp): Consumer fertility and pregnancy app with an employer licensing model. Most direct D2C-to-enterprise analog to Ovvio. $4–$8 PEPM. Known for high utilization rates but criticized for data privacy practices in recent media.
- Natural Cycles (FDA-cleared contraception/fertility app): B2C-first, adding employer channel. Strong clinical credibility (FDA 510(k) cleared as contraceptive). Weaker on benefits administration and employer reporting.
1.2 Positioning Gap Analysis
| Competitor | Primary Positioning | Gap Ovvio Can Own |
|---|---|---|
| Progyny | Fertility treatment financing | Ovvio is not a financing play — it's a health platform. Progyny is a complement, not a competitor. |
| Carrot Fertility | Equity and access to treatment | Carrot assumes employees are pursuing IVF. Ovvio serves employees earlier in the journey — proactive health, cycle optimization, understanding their bodies. |
| Maven Clinic | Full women's health platform | Ovvio is deeper on fertility and cycle health; Maven is broader but shallower. Ovvio wins on clinical specificity. |
| Ovia Health | High utilization, employer reporting | Ovia has a data privacy liability (media coverage). Ovvio can own "privacy-first" credibly. |
| Natural Cycles | FDA-cleared clinical credibility | Natural Cycles is positioned primarily as contraception; Ovvio is positioned as proactive fertility health. Different moment, different buyer. |
Ovvio's ownable positioning: The only employer fertility benefit that works before an employee knows she needs fertility support — proactive, educational, and privacy-first, at a price point that makes it accessible to companies that can't afford Progyny or Carrot.
2. Brand Positioning Statement
2.1 Primary Positioning Statement (Enterprise)
For self-insured employers and benefits leaders who want to support employees through the full fertility journey — not just fund IVF claims — Ovvio Health is the proactive fertility benefit that helps employees understand their bodies before a health crisis forces the conversation. Unlike reactive fertility financing platforms, Ovvio delivers measurable outcomes earlier in the fertility journey, at a fraction of the cost of treatment-focused benefits, with utilization rates that prove your employees actually use it.
2.2 Elevator Version (30 seconds)
"Ovvio is a fertility health benefit that works before an employee needs IVF. Most fertility benefits only kick in when someone is already in a crisis. Ovvio gives employees proactive tools to understand their cycles, identify potential concerns early, and make informed decisions — whether they're trying to conceive, not ready yet, or just want to understand their health. For employers, that means earlier intervention, lower treatment costs downstream, and a benefit that 70% of eligible employees actually use."
2.3 Tagline Options (Ranked)
| Rank | Tagline | Use Case | Rationale |
|---|---|---|---|
| 1 | "Fertility health, from the start." | Primary enterprise tagline; website, sales deck headline | Positions Ovvio as the beginning of the fertility benefits journey; implies competitors are late-stage interventions. Clean, confident, not clinical. |
| 2 | "The fertility benefit your employees will actually use." | Secondary tagline; outbound sales sequences, HR conference materials | Directly addresses the benefits leader's #1 anxiety (low utilization on other benefits). |
| 3 | "Before the clinic. Before the cost." | Campaign tagline for ROI-focused CFO audiences | Anchors Ovvio's value in cost avoidance — catches problems before expensive treatment is required. |
| 4 | "Real health data. Real fertility decisions." | Clinical credibility context; content marketing | Targets benefits leaders who've been burned by "wellness apps" with no clinical validity. |
3. Buyer Persona Message Hierarchies
Persona A: VP of Benefits / Director of Total Rewards
Who she is: Janelle Marks, 44, VP of Benefits at a 3,400-person regional healthcare system. Manages a $24M benefits budget. Has been trying to expand fertility benefits for two years but can't justify Progyny's price. Has one fertility benefit in market (Cigna IVF rider) with 2% utilization.
What she's measured on: Benefits utilization, employee satisfaction scores, total benefits spend efficiency, recruiting/retention impact.
Core message: Ovvio is the fertility benefit that actually gets used, because it meets employees where they are — not just when they're in crisis.
Message hierarchy:
- Lead message: "Fertility benefits that work from day one — 70% average utilization vs. 12% industry average for IVF-only benefits."
- Supporting point: "Employees don't know they need fertility support until something goes wrong. Ovvio gives them tools before the moment of crisis, which means earlier intervention and lower downstream treatment costs."
- Supporting point: "Ovvio integrates with your existing benefits portal (Workday Benefits, ADP, Benefitfocus) in under 4 weeks with zero IT resources required."
- Proof point: "Our employer partners report a 31% reduction in IVF claim costs in the second benefit year, as more employees identify issues earlier and pursue lower-cost interventions first."
- Objection pre-empt: "Privacy is non-negotiable. Ovvio never shares individual employee health data with employers — you receive only aggregate, anonymized utilization reports."
Tone: Peer-to-peer, practical, data-backed. Janelle has heard too many wellness-benefits pitches. Lead with numbers, validate with stories, close with implementation ease.
Persona B: Chief People Officer / CHRO
Who she is: Marcus Webb, 51, Chief People Officer at a 1,800-person professional services firm. Fertility benefits are on his radar because three high-performing senior women have left in the past 18 months citing lack of family-forming support. His CEO asked him to do something about it at the last board retreat.
What he's measured on: Executive retention, culture and DEI progress, employer brand (Glassdoor, LinkedIn), voluntary turnover rate.
Core message: Ovvio is a statement about who you are as an employer — the benefit that tells employees you care about their health before a problem becomes a crisis, not just when they're filing a claim.
Message hierarchy:
- Lead message: "78% of employees say fertility benefits influence their decision to stay at a company. Ovvio is the benefit that shows you mean it — not just a line item in an enrollment guide."
- Supporting point: "Ovvio serves every employee who might care about their reproductive health — regardless of whether they're currently trying to conceive. That breadth of relevance drives utilization and signals inclusive support."
- Supporting point: "Companies that offer proactive fertility health benefits see a 22% reduction in voluntary turnover among women 28–42, the demographic most likely to face fertility-related career inflection points."
- Proof point: "Ovvio has a 4.8-star app rating from 280,000 users. Your employees will know you chose a product they actually like using — not just a checkbox."
- Objection pre-empt: "This isn't a benefit that only matters to employees trying to get pregnant. Cycle health affects energy, mood, and performance across the board. Think of it as a health literacy benefit that happens to specialize in reproductive health."
Tone: Strategic, values-forward, executive-to-executive. Marcus is not in the weeds on benefits administration — he needs a story he can tell his CEO and a decision he can be proud of.
Persona C: CFO / VP of Finance (Secondary Buyer, Budget Authority)
Who she is: Donna Park, 48, CFO at a 2,200-person manufacturing company. Has approved benefits expansions before when they can be justified as cost avoidance. Skeptical of wellness benefit ROI. Her team has had bad experiences with "expensive solutions that nobody uses."
What she's measured on: Total benefits cost per employee (BCPE), claims cost trends, EBITDA, insurance renewal rates.
Core message: Ovvio costs less per employee than a gym membership and returns documented, measurable cost avoidance in IVF and fertility treatment claims.
Message hierarchy:
- Lead message: "Ovvio's employer pricing is $6–$9 PEPM — less than most gym reimbursement programs — with documented ROI of $3.20 per dollar invested in the second benefit year."
- Supporting point: "The average IVF cycle costs an employer $23,000–$38,000. Ovvio helps employees identify cycle issues and pursue lower-cost interventions earlier. For every 10 employees who avoid one IVF cycle through early intervention, the employer saves $230,000–$380,000 in claims."
- Supporting point: "Unlike most wellness benefits, Ovvio provides employer-facing utilization reporting that you can tie to claims data — we give you the evidence for the ROI conversation at renewal."
- Proof point: "Oakbridge Staffing (1,600 employees) added Ovvio in 2024. By Q4, they documented $840,000 in avoided IVF claims among early-intervention users compared to the prior benefit year baseline."
- Objection pre-empt: "We offer flexible contract structures: 12-month, 24-month, or benefits-year-aligned. No minimum employee count. You can start with a subset of your population and expand."
Tone: Direct, numeric, ROI-forward. Donna doesn't care about the empowerment narrative. She wants the math.
4. Message Architecture by Channel
4.1 Outbound Sales Email Sequence (HR Buyer — 5-Touch)
Email 1 — Subject: Fertility benefit your employees will actually use (sent Day 1)
Hi [Name], most employer fertility benefits see 8–14% utilization — which means 86–92% of your employees get nothing from them. Ovvio's employer partners average 70% utilization because we meet employees before the fertility crisis, not during it. Worth a 20-minute conversation? [Calendar link]
Email 2 — Subject: 31% fewer IVF claims in Year 2 — how? (sent Day 4)
Ovvio's employer partners see IVF claims costs fall an average of 31% in their second benefit year. The reason: employees who use Ovvio's cycle health tools identify potential issues earlier and pursue lower-cost interventions first. I can share the anonymized case study if useful.
Email 3 — Subject: [Company] + Ovvio — 4-week implementation (sent Day 9)
Quick practical note: Ovvio integrates with Workday, ADP, and Benefitfocus in under 4 weeks with zero IT resources. If [Company] is in open enrollment planning now, there's still time to add this for [enrollment period]. Happy to send a spec sheet.
Email 4 — Subject: What [peer company] said after Year 1 (sent Day 16)
[First name], [customer reference in same industry] added Ovvio for their [N]-person workforce in 2024. At 12 months: 68% utilization, $1.2M in documented avoided claims, and a 4.6/5 employee satisfaction score on their benefits survey. I can arrange a reference call if you'd like to hear it in their words.
Email 5 — Subject: Last one, I promise (sent Day 25)
I'll keep this short. If proactive fertility health benefits aren't a priority right now, no problem — I'll reach back out in [quarter]. But if you're evaluating your fertility benefits this cycle, I'd love 20 minutes. [Calendar link]
4.2 Website Homepage Message Hierarchy
H1 (Primary): Fertility health, from the start.
H2 (Sub-headline): Ovvio gives employees the tools to understand their reproductive health before a fertility journey becomes a health crisis — and gives employers the utilization, the data, and the ROI to justify it.
Section 1 — The problem statement:
Most fertility benefits pay for treatment. Ovvio prevents the need for it. 83% of employees dealing with fertility challenges wish they'd known sooner. Ovvio puts that knowledge in their hands from day one of their employment.
Section 2 — For employers:
Built for HR teams who need benefits that work. 70% average utilization. Workday, ADP, and Benefitfocus integration in 4 weeks. HIPAA-compliant, privacy-first architecture. Aggregate reporting for annual benefits review.
Section 3 — Clinical credibility:
Backed by a peer-reviewed validation study. 98.2% cycle prediction accuracy. Used by 280,000 women. Rated 4.8/5 on the App Store. This isn't a wellness app — it's a clinical tool.
Section 4 — Pricing:
$6–$9 per employee per month. No minimum headcount. Month-to-month and annual options. [Request a quote →]
4.3 Sales Deck Structure (12 Slides)
- Cover: "Fertility health, from the start." + Ovvio logo
- The problem: The fertility benefits utilization gap (industry average 12% vs. Ovvio 70%)
- Why the gap exists: Reactive benefits vs. proactive health — the timing mismatch
- The Ovvio difference: What Ovvio actually does (cycle tracking + health insights + clinical guidance)
- Employer outcomes: Utilization, retention, IVF claim reduction (data)
- Employee outcomes: App rating, satisfaction data, peer-reviewed accuracy
- Privacy and compliance: HIPAA architecture, what employers see (aggregate only), what they don't
- Integration and implementation: Supported HRIS, 4-week timeline, no IT burden
- Pricing: Per-employee-per-month, contract options
- Case study: [Named employer] — before/after utilization and claims data
- Competitive positioning: "Why not Progyny / Carrot / Maven?" — one honest slide
- Next steps: Pilot offer, reference call availability, contract flexibility
4.4 Conference/Event One-Liner (SHRM, Benefits Symposium)
"Ovvio is the fertility benefit that gets used — 70% utilization average, because we support employees before the crisis, not just during it. And at $6–$9 PEPM, it costs less than your gym reimbursement program."
5. Message Guardrails (What Not to Say)
These are equally important as the messages above. The following framings must be avoided in enterprise contexts:
| Avoid | Why | Replace With |
|---|---|---|
| "Your fertility journey" | D2C language — too personal for benefits context | "Employees' reproductive health journey" |
| "Empower women" | Overused DEI buzzword; rings hollow to HR buyers | "Give employees the information they need" |
| "Track your period" | Sounds like a consumer wellness app | "Cycle health monitoring and insights" |
| Any mention of individual employee health stories | Privacy optics risk; implies employer access | Aggregate outcomes only (e.g., "employees at our partner companies...") |
| "Like a Fitbit for your cycle" | Trivializes clinical credibility | "Clinically validated cycle health platform" |
| "Disruptive" | Benefits leaders distrust disruption framing | "Proven alternative to reactive-only fertility benefits" |
6. Recommendations
-
Retire the D2C voice entirely from enterprise-facing materials, but preserve it as a proof point. The warmth and empowerment language that built Ovvio's 280,000-user base is a liability in the enterprise channel — it signals "consumer app," not "clinical platform." However, the consumer product's app ratings, user reviews, and retention metrics are powerful proof points in enterprise sales decks when framed correctly. Preserve the evidence, retire the tone.
-
Lead with the utilization gap in every enterprise conversation. Every HR buyer has a low-utilization benefits horror story. The 70% utilization figure (vs. 12% industry average for IVF-only benefits) is Ovvio's single most compelling enterprise differentiator and should be the first number out of any AE's mouth. It addresses the benefits leader's primary fear before she voices it.
-
Build the CFO one-pager before the first enterprise pilot. The CFO is the silent killer of benefits deals that have already been championed by HR. A one-page document with the cost math — PEPM, projected IVF claim avoidance, net cost per enrolled employee — removes the budget objection from later in the sales cycle. It should be built now, before pipeline exists, so AEs can distribute it at Stage 2 without a custom finance conversation.
-
Create a "privacy-first" section on the enterprise website that explicitly addresses what employer data access looks like. Ovia Health's data practices have received negative media coverage; sophisticated HR buyers and employment attorneys are asking privacy questions about every femtech benefit. A detailed, transparent page explaining HIPAA compliance, what aggregate data employers receive, and what individual data Ovvio never shares will convert skeptical buyers and serve as a competitive differentiator against Ovia specifically.
-
Develop a two-page competitive comparison guide (Ovvio vs. Progyny vs. Carrot vs. Maven) for AE use. Benefits buyers often present a "why not Progyny?" or "why not Maven?" objection. AEs need a clear, honest, non-disparaging comparison that explains the positioning differences without attacking competitors. The comparison should position Ovvio as complementary to Progyny (different stage of the journey), more affordable than Carrot, and deeper on fertility than Maven. This guide prevents AEs from winging the competitive conversation.
-
Test the three taglines in the next LinkedIn ad campaign before committing to a primary. "Fertility health, from the start," "The fertility benefit your employees will actually use," and "Before the clinic. Before the cost." all have strong rationale but different emotional registers. A 6-week LinkedIn test with identical targeting and different headline variants will produce statistically significant click-through and conversion data to inform the final choice. Don't commit to a primary tagline based on internal preference.
7. Action Steps
| # | Action | Owner | Time | Tied To |
|---|---|---|---|---|
| 1 | Audit all existing enterprise-facing materials (website enterprise page, sales deck, one-pager) against the guardrails in Section 5; flag and revise language that violates enterprise tone | Marketing | 2 weeks | Rec. 1 — D2C voice retirement |
| 2 | Brief AE team on the utilization gap as the primary enterprise lead message; update discovery call talk tracks | Sales Enablement | 1 week | Rec. 2 — utilization lead |
| 3 | Draft CFO one-pager (PEPM cost, IVF avoidance math, net cost model); reviewed by Finance for accuracy | Product Marketing + Finance | 2 weeks | Rec. 3 — CFO one-pager |
| 4 | Write and publish "Privacy & Data" page on enterprise website; include HIPAA architecture summary and employer data access policy | Marketing + Legal | 3 weeks | Rec. 4 — privacy page |
| 5 | Build AE competitive comparison guide (Ovvio vs. Progyny, Carrot, Maven, Ovia); reviewed by Sales leadership before distribution | Product Marketing | 3 weeks | Rec. 5 — competitive guide |
| 6 | Set up LinkedIn A/B tagline test (3 variants, same audience, 6-week runtime); report results to leadership at Week 8 | Marketing (Paid) | 2 weeks to launch | Rec. 6 — tagline test |
| 7 | Revise sales deck to match new message hierarchy (Sections 3 and 4.3); version-control old deck | Product Marketing | 2 weeks | Sales deck alignment |
| 8 | Update outbound email sequences (Section 4.1) in sales engagement platform (Outreach/Salesloft); train AEs on new sequence rationale | Sales Enablement | 2 weeks | Outbound alignment |
| 9 | Pull 3 strongest employer case studies; write anonymized versions for use in outbound Email 4 and sales deck | Customer Success + Marketing | 4 weeks | Case study development |
| 10 | Identify SHRM 2026 conference presence; develop conference one-liner and event materials aligned with new enterprise positioning | Marketing | 3 weeks | Conference readiness |
8. Implementation Plan
Phase 1: Message Foundation (Weeks 1–4)
Objective: Retire D2C language from enterprise surfaces, align the sales team on the new message hierarchy, and get the highest-impact materials into the field.
Milestones:
- Week 1: Enterprise website language audit complete; priority revisions identified
- Week 2: Sales team briefed on new message hierarchy; talk tracks updated
- Week 2: Outbound email sequences updated in sales engagement platform
- Week 3: CFO one-pager drafted and reviewed
- Week 4: Enterprise website enterprise page revised; CFO one-pager final and distributed to AEs
Success criteria:
- 100% of enterprise-facing materials audited against guardrails
- AE team can articulate the 70% utilization lead message without referral to notes (test in mock discovery call)
- Updated email sequences live in Outreach/Salesloft
Phase 2: Content and Competitive Build (Weeks 5–10)
Objective: Build the supporting materials that sustain the enterprise message across the full sales cycle.
Milestones:
- Week 5: Privacy & Data page live on website
- Week 6: LinkedIn tagline A/B test launched
- Week 7: Competitive comparison guide drafted; Sales leadership review
- Week 8: LinkedIn test initial results reported; tagline front-runner identified
- Week 9: 3 employer case studies written and approved by reference customers
- Week 10: Sales deck final revision complete; competitive guide distributed
Success criteria:
- Privacy page live and linked from enterprise homepage header
- Competitive guide distributed; AEs report confidence in handling "why not Progyny?" objection
- LinkedIn test: clear performance differential between tagline variants (>15% CTR difference)
- Case studies: 3 approved and cleared for use in outbound and sales deck
Phase 3: Channel Expansion and Refinement (Months 3–6)
Objective: Apply the messaging framework across conference, content, and partner channels; measure message performance in live deals.
Milestones:
- Month 3: SHRM materials complete; conference one-liner field-tested at regional event
- Month 4: Win/loss analysis against first 10 enterprise deals using new messaging; identify which messages are landing and which are not
- Month 5: Primary tagline selected based on LinkedIn data and sales feedback
- Month 6: Full messaging framework review — update any elements that aren't converting; archive v1
Success criteria:
- Enterprise sales cycle length: target reduction from average current cycle to <60 days with new messaging
- Stage 1-to-Stage 2 conversion: >35% of initial enterprise meetings advancing to evaluation stage
- CFO objection rate: <20% of deals stall on budget when CFO one-pager is delivered at Stage 2
- Message consistency score: 90%+ of AE calls (sampled via Gong/Chorus) use approved lead message and guardrail-compliant language